167 related articles for article (PubMed ID: 21569455)
21. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.
Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR
JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899
[TBL] [Abstract][Full Text] [Related]
22. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor and amyotrophic lateral sclerosis: the interplay with exercise and noninvasive ventilation.
Carilho R; de Carvalho M; Swash M; Pinto S; Pinto A; Costa J
Muscle Nerve; 2014 Apr; 49(4):545-50. PubMed ID: 23868282
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
[TBL] [Abstract][Full Text] [Related]
26. CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients.
Moreau C; Gosset P; Brunaud-Danel V; Lassalle P; Degonne B; Destee A; Defebvre L; Devos D
Amyotroph Lateral Scler; 2009 Jun; 10(3):175-81. PubMed ID: 19177252
[TBL] [Abstract][Full Text] [Related]
27. Elevated serum angiogenin levels in ALS.
Cronin S; Greenway MJ; Ennis S; Kieran D; Green A; Prehn JH; Hardiman O
Neurology; 2006 Nov; 67(10):1833-6. PubMed ID: 17130418
[TBL] [Abstract][Full Text] [Related]
28. Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model.
Shanmukha S; Narayanappa G; Nalini A; Alladi PA; Raju TR
Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29666144
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin concentration in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Janik P; Kwiecinski H; Sokolowska B; Niebroj-Dobosz I
J Neural Transm (Vienna); 2010 Mar; 117(3):343-7. PubMed ID: 20012656
[TBL] [Abstract][Full Text] [Related]
30. CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis.
Tateishi T; Yamasaki R; Tanaka M; Matsushita T; Kikuchi H; Isobe N; Ohyagi Y; Kira J
J Neuroimmunol; 2010 May; 222(1-2):76-81. PubMed ID: 20381883
[TBL] [Abstract][Full Text] [Related]
31. Analysis of smoking and LPO in ALS.
Anand A; Gupta PK; Prabhakar S; Sharma S; Thakur K
Neurochem Int; 2014 May; 71():47-55. PubMed ID: 24726768
[TBL] [Abstract][Full Text] [Related]
32. Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden.
Simpson EP; Henry YK; Henkel JS; Smith RG; Appel SH
Neurology; 2004 May; 62(10):1758-65. PubMed ID: 15159474
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation?
Rentzos M; Rombos A; Nikolaou C; Zoga M; Zouvelou V; Dimitrakopoulos A; Alexakis T; Tsoutsou A; Samakovli A; Michalopoulou M; Evdokimidis J
Acta Neurol Scand; 2010 Dec; 122(6):425-9. PubMed ID: 20219021
[TBL] [Abstract][Full Text] [Related]
35. Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS.
Moreau C; Devos D; Brunaud-Danel V; Defebvre L; Perez T; Destée A; Tonnel AB; Lassalle P; Just N
J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):255-7. PubMed ID: 16421133
[TBL] [Abstract][Full Text] [Related]
36. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
[TBL] [Abstract][Full Text] [Related]
37. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue.
Henkel JS; Engelhardt JI; Siklós L; Simpson EP; Kim SH; Pan T; Goodman JC; Siddique T; Beers DR; Appel SH
Ann Neurol; 2004 Feb; 55(2):221-35. PubMed ID: 14755726
[TBL] [Abstract][Full Text] [Related]
38. Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia.
Mishra PS; Vijayalakshmi K; Nalini A; Sathyaprabha TN; Kramer BW; Alladi PA; Raju TR
J Neuroinflammation; 2017 Dec; 14(1):251. PubMed ID: 29246232
[TBL] [Abstract][Full Text] [Related]
39. Evaluating the levels of CSF and serum factors in ALS.
Guo J; Yang X; Gao L; Zang D
Brain Behav; 2017 Mar; 7(3):e00637. PubMed ID: 28293476
[TBL] [Abstract][Full Text] [Related]
40. VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis.
Nygren I; Larsson A; Johansson A; Askmark H
Neuroreport; 2002 Dec; 13(17):2199-201. PubMed ID: 12488796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
